Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$407.69 - $446.08 $727,726 - $796,252
1,785 Added 217.95%
2,604 $1.09 Billion
Q4 2023

Feb 08, 2024

SELL
$343.0 - $410.68 $638,666 - $764,686
-1,862 Reduced 69.45%
819 $333 Million
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $494,419 - $529,916
1,462 Added 119.93%
2,681 $932 Million
Q2 2023

Aug 11, 2023

BUY
$314.42 - $351.91 $383,277 - $428,978
1,219 New
1,219 $429 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Inceptionr LLC Portfolio

Follow Inceptionr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inceptionr LLC with notifications on news.